Pingkian, Baby Girl -.
HRN: 23-53-58 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/16/2023
AMPICILLIN 250MG (VIAL)
08/16/2023
08/23/2023
IV
145mg
Q12
PSNB
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes